Delivery Order SPE2DB20D2104-SPE2DB24FS25T
- Not listed
- This federal contract award, valued at $14,780.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Myrbetriq ER 25 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of February 25, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver Myrbetriq ER 25 mg tablets. The $15,584.32 firm-fixed-price delivery order is for a contract with a performance period ending on May 11, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,862.84 firm-fixed-price delivery order is for the pharmaceutical product Myrbetriq ER 25 mg tablets. The contract has an ultimate completion date of October 30, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DX24FMCVF) valued at $7,216.05 for the supply of Myrbetriq ER 50 MG tablets. The contract, with a performance period through May 3, 2024, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $18,990.92 for the supply of Myrbetriq ER 25 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 19, 2022. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) on September 14, 2022. The $75,479.20 firm-fixed-price delivery order is for the supply of Myrbetriq ER 25 mg tablets. The contract has an ultimate completion date of September 15, 2022 and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., covers the delivery of Myrbetriq ER 50 mg tablets. The $71,722.97 firm fixed-price delivery order has a period of performance through February 23, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary mechanism for the company to provide a broad range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies, including Myrbetriq ER 25 mg tablets, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $27,649.35, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,775.07 for the medication Myrbetriq ER 50 mg tablets. The award was made on August 4, 2021, with a completion date of August 5, 2021. The contracting agency is the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Myrbetriq ER 50 mg tablets with a ceiling value of $16,492.57 and a completion date of February 29, 2024. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS25TDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Myrbetriq ER 25 mg tablets. The contract, valued at $2,030.40, is a firm fixed-price delivery order that will be completed by January 29, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/26/24 |